Interventional Care
EPA Approves PDI’s Sani-Cloth® Prime Wipes for Use Against SARS-CoV-2
The EPA has approved PDI’s claim that Sani-Cloth® Prime Germicidal Disposable Wipes are effective against SARS-CoV-2, the virus that causes COVID-19.
The EPA approval expanded the label claims for Sani-Cloth Prime wipes (EPA Reg No. 9480-12) to include deactivation of SARS-CoV-2, the virus that causes COVID-19, after one minute of contact time on hard, nonporous surfaces. Before a product can legally make efficacy claims against a particular pathogen, the claim must be approved by the EPA based on a thorough review of scientific data. According to the data provided by PDI Healthcare, the Sani-Cloth Prime wipes caused a 3-log reduction against the SARS-CoV-2 virus, which meets the EPA’s efficacy requirements. Prior to receiving approval for this claim, Sani-Cloth Prime wipes were included on EPA’s List N: Disinfectants for Coronavirus (COVID-19).
Microbac Lab tested the wipes in compliance with EPA Product Performance Test Guideline OCSPP 810.2200: Disinfectants for Use on Environmental Surfaces, Guidance for Efficacy Testing. When performing the testing, the lab applied the virus to a surface and let it dry. They then applied the wipe to the surface, recovered what was left on the surface, and applied it to cell cultures. They were then able to tell how effective the cloth was at deactivating the virus based on how many viable cells remained.
To learn more about PDI’s other disinfectant products currently being tested against the SARS-CoV-2 virus, click here.